Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980275 · ClinicalTrials.gov registry record
Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis
A clinical trial of Bilateral Vocal Cord Paralysis, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT03980275: Recruiting study of Bilateral Vocal Cord Paralysis, sponsored by Weill Medical College of Cornell University.
NCT03980275 is a study of Bilateral Vocal Cord Paralysis that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03980275, a study of Bilateral Vocal Cord Paralysis, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.
Primary Outcome
The DI is a standardized and validated tool to quantify patients' symptoms of upper airway dyspnea. It's a 10-item questionnaire. The lowest score is 0, which indicates that the patient is never experiencing dyspnea symptoms, and the highest is 40, which indicates that the patient is always experiencing dyspnea symptoms.
Conditions Studied
Study Locations (1)
New York
- Sean Parker Institute for the Voice - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-12-10 |
| Est. Completion | 2030-12-31 |
What NCT03980275 shows while recruiting
NCT03980275 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 1 condition, with Bilateral Vocal Cord Paralysis appearing as the primary indexed condition, and to 0 interventions.
NCT03980275 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03980275 about?
NCT03980275 is a clinical study titled "Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis". This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fold paralysis.
What is the current status of trial NCT03980275?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2019-12-10. Estimated completion is 2030-12-31.
What conditions does trial NCT03980275 study?
This clinical trial studies the following conditions: Bilateral Vocal Cord Paralysis.
Who is sponsoring clinical trial NCT03980275?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03980275 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI